Stockscreener 앱 받기
0.00
100.00%
-11.00
전일 마감가:
$11.00
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$18.95M
수익:
$8.62M
순이익/손실:
$-6.15M
주가수익비율:
0.00
EPS:
-11.03
순현금흐름:
$-5.32M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$11.00
Evoke Pharma Inc Stock (EVOK) Company Profile
명칭
Evoke Pharma Inc
전화
858-345-1494
주소
420 STEVENS AVENUE, SOLANA BEACH, CA
EVOK을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVOK
Evoke Pharma Inc
|
0.00 | 18.95M | 8.62M | -6.15M | -5.32M | -11.03 |
|
ZTS
Zoetis Inc
|
127.17 | 55.90B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.31 | 51.72B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.91 | 44.71B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.01 | 37.30B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
45.79 | 20.48B | 0 | -5.87M | -767.30K | -0.45 |
Evoke Pharma Inc Stock (EVOK) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2020-06-22 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2019-03-05 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2018-03-08 | 재확인 | B. Riley FBR, Inc. | Buy |
| 2017-10-19 | 재개 | FBR & Co. | Buy |
| 2017-03-16 | 재확인 | Rodman & Renshaw | Buy |
| 2017-01-30 | 업그레이드 | Laidlaw | Neutral → Buy |
| 2017-01-05 | 업그레이드 | Rodman & Renshaw | Neutral → Buy |
| 2016-12-23 | 재확인 | Rodman & Renshaw | Neutral |
| 2016-07-19 | 재확인 | FBR Capital | Outperform |
| 2016-07-19 | 다운그레이드 | Noble Financial | Buy → Hold |
| 2016-07-18 | 다운그레이드 | Rodman & Renshaw | Buy → Neutral |
| 2016-03-16 | 개시 | Northland Capital | Outperform |
| 2016-03-14 | 재확인 | Ascendiant Capital Markets | Buy |
| 2016-02-17 | 재개 | FBR Capital | Outperform |
| 2014-12-03 | 재확인 | MLV & Co | Buy |
| 2014-11-07 | 개시 | MLV & Co | Buy |
| 2014-04-22 | 개시 | Laidlaw | Buy |
| 2013-11-19 | 개시 | Aegis Capital | Buy |
모두보기
Evoke Pharma Inc 주식(EVOK)의 최신 뉴스
Evoke Pharma Leads Micro-Cap Stocks with 137.07% Return Over Past Year - MarketsMojo
Evoke Pharma Leads Micro-Cap Stocks with 149.43% Return Over Past Year - MarketsMojo
Evoke Pharma Achieves 304.41% Return, Leading Micro-Cap Stock Performance - MarketsMojo
Will Evoke Pharma Inc. stock benefit from commodity prices2025 AllTime Highs & Low Risk High Win Rate Picks - ulpravda.ru
Evoke Pharma Achieves 313.53% Return Amid Mixed Micro-Cap Performance - MarketsMojo
What technical charts say about Evoke Pharma Inc. stock - ulpravda.ru
Will Evoke Pharma Inc. stock keep outperforming rivalsJuly 2025 Fed Impact & Daily Risk Controlled Trade Plans - ulpravda.ru
Will Evoke Pharma Inc. stock gain from strong economyWeekly Profit Analysis & High Accuracy Trade Alerts - ulpravda.ru
Why Evoke Pharma Inc. stock is considered a top pickEarnings Trend Report & Fast Entry High Yield Stock Tips - ulpravda.ru
How Evoke Pharma Inc. stock performs in rate cut cyclesWeekly Trade Summary & Capital Efficiency Focused Strategies - ulpravda.ru
How Evoke Pharma Inc. stock performs in stagflationTrade Analysis Report & Stepwise Swing Trade Plans - ulpravda.ru
Evoke Pharma, Inc.Common Stock (NQ: EVOK - FinancialContent
How Evoke Pharma Inc. stock performs after earningsSwing Trading Watchlist & Free Strong Return On Assets - ulpravda.ru
Evoke Pharma Leads Pharmaceuticals Sector with 137.07% Annual Return - MarketsMojo
Operating cash flow per share of Evoke Pharma, Inc. – SWB:EV0 - TradingView — Track All Markets
Evoke Pharma Achieves 304.41% Return Amid Strong Market Performance - MarketsMojo
Evoke Pharma Achieves 313.53% Return; InnovAge Holding Up 31.39% - Markets Mojo
Evoke Pharma Achieves 313.53% Return Amid Market Volatility - Markets Mojo
Evoke Pharma Leads with 124.95% Return Among Notable Stock Performers - Markets Mojo
Evoke Pharma Leads Stock Performance with 148.87% Return in Pharmaceuticals Sector - Markets Mojo
Evoke Pharma Leads with 148.87% Return Among High-Performing Stocks - MarketsMojo
Bank Watch: Will Evoke Pharma Inc stock gain from strong economyQuarterly Earnings Report & Smart Allocation Stock Reports - moha.gov.vn
Evoke Pharma Leads Impressive Stock Returns with 126.34% Gain - MarketsMojo
Evoke Pharma Achieves 318.7% Return, Leading Pharmaceutical Stocks Performance - MarketsMojo
Evoke Pharma Leads Six-Month Stock Returns with 316.67% Gain - Markets Mojo
Evoke Pharma Achieves 316.67% Return, Leading Pharmaceutical Sector Performance - MarketsMojo
Evoke Pharma, Inc. Financial Disclosures & Filings - TradingView — Track All Markets
Evoke Pharma Leads Stocks with 124.49% Return in Pharmaceuticals Sector - MarketsMojo
Evoke Pharma Leads Six-Month Stock Returns with 298.55% Gain - MarketsMojo
Evoke Pharma Achieves 340% Return, Leading Recent Stock Performers - MarketsMojo
Evoke Pharma Leads Stock Returns with 121.77% Gain Over Past Year - MarketsMojo
Evoke Pharma Leads Stock Performance with 100.36% Return in Past Year - MarketsMojo
Evoke Pharma Leads Six-Month Stock Performance with 303.23% Return - MarketsMojo
Why Evoke Pharma Inc. stock attracts global investorsMarket Trend Summary & Verified Technical Signals - Улправда
Is Evoke Pharma Inc. stock dividend yield sustainable2025 Key Highlights & Community Consensus Trade Alerts - Улправда
Can Evoke Pharma Inc. stock sustain revenue growthAnalyst Downgrade & Low Risk Investment Opportunities - Улправда
Aug Sentiment: Is Evoke Pharma Inc. stock dividend yield sustainable2025 Pullback Review & High Yield Equity Trading Tips - Улправда
Can Evoke Pharma Inc. stock hit analyst price targetsWeekly Trade Recap & Proven Capital Preservation Methods - DonanımHaber
Evoke Pharma Leads Stock Performance with 150% Return in Past Year - Markets Mojo
Evoke Pharma Leads Six-Month Stock Performance with 296.4% Return - MarketsMojo
Will Evoke Pharma Inc. stock benefit from infrastructure spendingJuly 2025 Snapshot & Weekly High Return Opportunities - Улправда
Is Evoke Pharma Inc. stock trading near support levels2025 Trading Volume Trends & Community Driven Trade Alerts - Улправда
Evoke Pharma and QOL Medical Announce Expiration of Tender Offer - BioSpace
Evoke Pharma acquired by QOL Medical, shares to be delisted from Nasdaq - Investing.com Canada
Evoke Pharma (NASDAQ: EVOK) clears shelf registrations following QOL Medical deal - Stock Titan
Evoke Pharma (EVOK) deregisters unsold securities following QOL Medical merger - Stock Titan
Evoke Pharma Inc (EVOK) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.37%
1.55%
자본화:
|
볼륨(24시간):